CONTACT US FOR YOUR PERSONALIZED PROPOSAL

Customized, cutting-edge research services for the pharmaceutical, biotech and cannabis industries for the development of innovative products that meet patient and physician needs.

Your international resource in medical cannabis research and innovation

Research Services

The interest in cannabinoid-based medicines has evolved rapidly in international pharmaceutical and cannabis industries.

Our clinical experience and the emergence of Real-World Evidence from our Santé Cannabis research database allows the demonstration of the outcomes, safety and effectiveness of medical cannabis products for an extensive array of symptoms and conditions. Our data can provide the foundation on which to build an innovative R&D program for any company.

Our Research Services

To develop a world-leading program, review our unique service offering below and contact us to receive a customized proposal.

MEDICAL CANNABIS RESEARCH

The significant potential of cannabinoid-based medicines to meet unmet clinical and patient needs is clear. While regulatory challenges and research complexity remains, more scientific evidence emerges every year, making the research & development of innovative cannabinoid-based medicines increasingly competitive. 

Partnerships between innovative organizations with complementary experience and expertise are key to successful business development in this emergent sector.

This is why, since 2014,  we offer clinical research solutions to companies willing to explore development of new products that have the potential to become approved treatments and make positive impacts in patients’ lives.

Our most popular packages are the Real-World Data Services and Clinical Trial Packages. Contact us for more details on how we can get your study started. 

CLINICAL RESEARCH PROGRAM CONSULTING

Clinical research to support the effectiveness of medical cannabis products to treat specific indications remains limited despite the market development worldwide. To develop an innovative clinical research program to address market gaps and ensure product differentiation and post-market growth, collaboration with experienced medical cannabis clinicians and researchers is a critical asset. Santé Cannabis provides expert advisory services to support company objectives and design a clinical research program for success.

  • Scoping assessment of published data and literature to evaluate existing evidence-based data and research gaps
  • Analysis of Santé Cannabis patient database to provide recommendations for most promising indications and study populations
  • Report writing and liaison with clinical experts to design clinical trials that address market needs
  • Product development recommendations on cannabinoid and terpene formulations, formats and dosing
MEDICAL ADVISORY & PUBLIC RELATIONS

Engagement with medical professionals for cannabinoid and cannabis research programs is challenging in the current environment. Our team delivers advisory board meetings and outreach plans for pharmaceutical, biotech and cannabis companies.

  • Organization and execution of Medical, Clinical or Scientific Advisory Board Meetings, both virtually and in-person
  • Healthcare professional, patient and stakeholder community engagement
  • Development of medical experts and spokespeople for media and public relations
  • Assessment and evaluation of global market opportunities
SCIENTIFIC REPORT WRITING & DISSEMINATION

Our report development can include a scoping review of literature on existing evidence-based data and research gaps on cannabinoid-based medicines, data analysis from Santé Cannabis Real-World Data and expert strategic consultation to design clinical trials and product development programs for success.

In addition, successful completion of a clinical trial in cannabinoid-based medicine is an achievement that demands a comprehensive and strategic plan for regulators, and potential for data dissemination and knowledge transfer to the public. Within a framework of limited published data, such knowledge transfer supports the credibility of a long-term research program and increases brand awareness in a crowded industry landscape.

  • Literature review from our extensive and unique medical cannabis library
  • Analysis and interpretation of RWD from the Santé Cannabis database by medical experts
  • Strategic recommendations based on analysis of the global market for cannabinoid-based medicines
  • Recommendations for data dissemination, design of presentations and marketing materials for meetings, conferences and knowledge transfer to healthcare professionals and patients, and other stakeholders
  • Publication and submission by medical and research professionals
REAL-WORLD DATA

Real-world data (RWD) is emerging as an opportunity to generate evidence that is accessible, dependable and innovative. Our RWD originates from our patient-centred clinic model where patients are assessed, treated and followed in a controlled clinical setting:

  • All data is collected and verified by our diverse team of medical experts including specialist physicians and certified nurses
  • Our operational procedures are rigorous and standardized
  • Our data collection protocol is approved by the McGill University Ethics Board Committee

 

CUSTOMIZED DATA EXTRACTION AND ANALYSIS FROM SANTÉ CANNABIS DATABASE (RWD) CAN INCLUDE:

  • Patients demographic information (age, sex, etc
  • Patient diagnostic and related symptoms 
  • Detailed product information (formulation, dosing, chemovars, etc
  • Product safety, frequency and severity of adverse effects
  • Effectiveness data 

Real-world evidence can be utilized to collect specific, customized data to address company objectives and development questions by prospective study design, analysing the effects of your product, or similar ones currently in use by Canadian patients.

 

TRIAL DEVELOPMENT

FROM PHASE I TO IV

Working with an experienced research partner is key to the design and execution of a successful research program. Offering compliant and robust clinical trial activities with the added experience as a medical cannabis clinical organization is what sets Santé Cannabis apart in the emergent global cannabis industry.

  • Trial design consulting including strategic recommendations based on analysis of the global market for cannabinoid-based medicines
  • Essential documents development by highly qualified team members, overseen by our regulatory experts and physicians: ICH-compliant study research protocols, informed consent form and Investigational Brochure documents that can be customized for use in Phase 1, 2 or 3 clinical trials, observational trials and registries
  • Trial and site budget development
REGULATORY STRATEGY & SUPPORT

Cannabis regulations and medical cannabis markets continue to evolve worldwide, requiring commitment and dedication to stay ahead. Whether your medical cannabis clinical trial runs in Canada or across the world, our unique regulatory expertise allows us to provide strategic development and execution.

For the development of global medical cannabis strategy, we provide support for international regulatory review for the market needs and the export of cannabinoid products.

 

  • Clinical Trial Application preparation and submission to regulatory authorities (Health Canada or FDA)
  • Submission to independent, private or institutional Research Ethics Boards (REB)
  • Applications for Cannabis Research License (Canada)
  • Regulatory consulting – learn how to navigate medical cannabis research

 

CLINICAL OPERATIONS

Each research project is unique. As such, we offer customized services as a package or an individual service basis depending on your needs and budget. Our expert team can assist you in selecting the requirements that are right for your clinical trial.

 

  • Project management and budget monitoring throughout the trial
  • Risk management
  • Vendor selection and management, including data and safety management vendors
  • Feasibility and Site selection for multi-site clinical trials outside Santé Cannabis sites
  • Trial start-up
  • Site management: patient identification and recruitment & retention plan
  • Investigational Product management specific to the needs of cannabis clinical trials
  • Audit/Inspection Support
  • Monitoring Services for sites external to Santé Cannabis
CLINICAL TRIAL SITE  

As a clinical trial site with cannabis research experience, a network of four clinic sites, thousands of patients and referring physicians across Quebec and a skilled clinical operations team, our team offers a unique cannabis clinical trial expertise to deliver trial site services that exceed expectations.

  • Trial subjects recruitment from our extensive network
  • Screening, enrollment and follow-up of recruited subjects at our clinics
  • Clinical data collection and monitoring
  • Sample collection and management
  • Trial close-out

A LEADING NETWORK INCLUDING

  • 4 Clinics           
  • 10,000+ patients        
  • 3,000+ physicians     
  • Virtual trial capabilities

 

CLINICAL TRIAL PACKAGES

A CRO AND CLINICAL TRIAL SITE DEDICATED TO MEDICAL CANNABIS AND CANNABINOID-BASED MEDICINES

  • PHASE I TO IV TRIAL DEVELOPMENT
  • REGULATORY STRATEGY AND SUPPORT
  • CLINICAL OPERATIONS
  • CLINICAL TRIAL SITE 

Santé Cannabis offers unmatched CRO and site services specifically tailored to suit the uniqueness of medical cannabis and cannabinoid research and its related regulations. Whether it be as a trial site or a CRO, we work as your partner to achieve your company objectives, offering creative solutions and opportunities to overcome challenges within timeline and budget.

We’ve partnered with international sponsors across the cannabis, biotech and pharmaceutical industries as well as academic institutional partners and investigators.

We have helped our sponsors overcome regulatory hurdles often resulting from changing regulations and inexperienced regulators. Our comprehensive literature database can support your plans and efficiently develop your clinical trial. We provide leading, screened vendors to ensure qualifications and understanding of the uniqueness of cannabis and cannabinoid research.

Why Canadian trials?

ADVANTAGES OF CLINICAL TRIALS IN CANADA WITH SANTÉ CANNABIS

  • An advantageous regulatory framework for product development and cannabinoid research within ICH guidelines and critical experience with international regulators
  • Cost-effective trials running for lower-cost in Canada compared to US or European countries
  • Specific experience running various cannabis trials and clinical trial operations, including during COVID-19 conditions
  • Our network of 4 clinics and more than 3000 referring physicians across the province of Québec to ensure recruitment efficiency
  • Our direct patient population of thousands of patients who have been treated and followed over the past 6 years for a compelling screening
  • The engagement of its medical cannabis expert team of physicians and registered nurses to ensure appropriate patient monitoring
  • Our dedicated research team to provide robust data collection and ensure participant retention
  • Contemporary offices with a in-house biological sample laboratory, allowing for fluid patient visits

Each clinical trial has a specific set of variables that drive the costs. We would be more than happy to provide a cost estimate for your clinical trial.

Please contact us to book a consultation to learn how we can support your clinical research program.

The significant potential of cannabinoid-based medicines to meet unmet clinical and patient needs is clear. While regulatory challenges and research complexity remains, more scientific evidence emerges every year, making the research & development of innovative cannabinoid-based medicines increasingly competitive. 

Partnerships between innovative organizations with complementary experience and expertise are key to successful business development in this emergent sector.

This is why, since 2014,  we offer clinical research solutions to companies willing to explore development of new products that have the potential to become approved treatments and make positive impacts in patients’ lives.

Our most popular packages are the Real-World Data Services and Clinical Trial Packages. Contact us for more details on how we can get your study started. 

Clinical research to support the effectiveness of medical cannabis products to treat specific indications remains limited despite the market development worldwide. To develop an innovative clinical research program to address market gaps and ensure product differentiation and post-market growth, collaboration with experienced medical cannabis clinicians and researchers is a critical asset. Santé Cannabis provides expert advisory services to support company objectives and design a clinical research program for success.

  • Scoping assessment of published data and literature to evaluate existing evidence-based data and research gaps
  • Analysis of Santé Cannabis patient database to provide recommendations for most promising indications and study populations
  • Report writing and liaison with clinical experts to design clinical trials that address market needs
  • Product development recommendations on cannabinoid and terpene formulations, formats and dosing

Engagement with medical professionals for cannabinoid and cannabis research programs is challenging in the current environment. Our team delivers advisory board meetings and outreach plans for pharmaceutical, biotech and cannabis companies.

  • Organization and execution of Medical, Clinical or Scientific Advisory Board Meetings, both virtually and in-person
  • Healthcare professional, patient and stakeholder community engagement
  • Development of medical experts and spokespeople for media and public relations
  • Assessment and evaluation of global market opportunities

Our report development can include a scoping review of literature on existing evidence-based data and research gaps on cannabinoid-based medicines, data analysis from Santé Cannabis Real-World Data and expert strategic consultation to design clinical trials and product development programs for success.

In addition, successful completion of a clinical trial in cannabinoid-based medicine is an achievement that demands a comprehensive and strategic plan for regulators, and potential for data dissemination and knowledge transfer to the public. Within a framework of limited published data, such knowledge transfer supports the credibility of a long-term research program and increases brand awareness in a crowded industry landscape.

  • Literature review from our extensive and unique medical cannabis library
  • Analysis and interpretation of RWD from the Santé Cannabis database by medical experts
  • Strategic recommendations based on analysis of the global market for cannabinoid-based medicines
  • Recommendations for data dissemination, design of presentations and marketing materials for meetings, conferences and knowledge transfer to healthcare professionals and patients, and other stakeholders
  • Publication and submission by medical and research professionals

Real-world data (RWD) is emerging as an opportunity to generate evidence that is accessible, dependable and innovative. Our RWD originates from our patient-centred clinic model where patients are assessed, treated and followed in a controlled clinical setting:

  • All data is collected and verified by our diverse team of medical experts including specialist physicians and certified nurses
  • Our operational procedures are rigorous and standardized
  • Our data collection protocol is approved by the McGill University Ethics Board Committee

 

CUSTOMIZED DATA EXTRACTION AND ANALYSIS FROM SANTÉ CANNABIS DATABASE (RWD) CAN INCLUDE:

  • Patients demographic information (age, sex, etc
  • Patient diagnostic and related symptoms 
  • Detailed product information (formulation, dosing, chemovars, etc
  • Product safety, frequency and severity of adverse effects
  • Effectiveness data 

Real-world evidence can be utilized to collect specific, customized data to address company objectives and development questions by prospective study design, analysing the effects of your product, or similar ones currently in use by Canadian patients.

 

FROM PHASE I TO IV

Working with an experienced research partner is key to the design and execution of a successful research program. Offering compliant and robust clinical trial activities with the added experience as a medical cannabis clinical organization is what sets Santé Cannabis apart in the emergent global cannabis industry.

  • Trial design consulting including strategic recommendations based on analysis of the global market for cannabinoid-based medicines
  • Essential documents development by highly qualified team members, overseen by our regulatory experts and physicians: ICH-compliant study research protocols, informed consent form and Investigational Brochure documents that can be customized for use in Phase 1, 2 or 3 clinical trials, observational trials and registries
  • Trial and site budget development

Cannabis regulations and medical cannabis markets continue to evolve worldwide, requiring commitment and dedication to stay ahead. Whether your medical cannabis clinical trial runs in Canada or across the world, our unique regulatory expertise allows us to provide strategic development and execution.

For the development of global medical cannabis strategy, we provide support for international regulatory review for the market needs and the export of cannabinoid products.

 

  • Clinical Trial Application preparation and submission to regulatory authorities (Health Canada or FDA)
  • Submission to independent, private or institutional Research Ethics Boards (REB)
  • Applications for Cannabis Research License (Canada)
  • Regulatory consulting – learn how to navigate medical cannabis research

 

Each research project is unique. As such, we offer customized services as a package or an individual service basis depending on your needs and budget. Our expert team can assist you in selecting the requirements that are right for your clinical trial.

 

  • Project management and budget monitoring throughout the trial
  • Risk management
  • Vendor selection and management, including data and safety management vendors
  • Feasibility and Site selection for multi-site clinical trials outside Santé Cannabis sites
  • Trial start-up
  • Site management: patient identification and recruitment & retention plan
  • Investigational Product management specific to the needs of cannabis clinical trials
  • Audit/Inspection Support
  • Monitoring Services for sites external to Santé Cannabis

As a clinical trial site with cannabis research experience, a network of four clinic sites, thousands of patients and referring physicians across Quebec and a skilled clinical operations team, our team offers a unique cannabis clinical trial expertise to deliver trial site services that exceed expectations.

  • Trial subjects recruitment from our extensive network
  • Screening, enrollment and follow-up of recruited subjects at our clinics
  • Clinical data collection and monitoring
  • Sample collection and management
  • Trial close-out

A LEADING NETWORK INCLUDING

  • 4 Clinics           
  • 10,000+ patients        
  • 3,000+ physicians     
  • Virtual trial capabilities

 

A CRO AND CLINICAL TRIAL SITE DEDICATED TO MEDICAL CANNABIS AND CANNABINOID-BASED MEDICINES

  • PHASE I TO IV TRIAL DEVELOPMENT
  • REGULATORY STRATEGY AND SUPPORT
  • CLINICAL OPERATIONS
  • CLINICAL TRIAL SITE 

Santé Cannabis offers unmatched CRO and site services specifically tailored to suit the uniqueness of medical cannabis and cannabinoid research and its related regulations. Whether it be as a trial site or a CRO, we work as your partner to achieve your company objectives, offering creative solutions and opportunities to overcome challenges within timeline and budget.

We’ve partnered with international sponsors across the cannabis, biotech and pharmaceutical industries as well as academic institutional partners and investigators.

We have helped our sponsors overcome regulatory hurdles often resulting from changing regulations and inexperienced regulators. Our comprehensive literature database can support your plans and efficiently develop your clinical trial. We provide leading, screened vendors to ensure qualifications and understanding of the uniqueness of cannabis and cannabinoid research.

ADVANTAGES OF CLINICAL TRIALS IN CANADA WITH SANTÉ CANNABIS

  • An advantageous regulatory framework for product development and cannabinoid research within ICH guidelines and critical experience with international regulators
  • Cost-effective trials running for lower-cost in Canada compared to US or European countries
  • Specific experience running various cannabis trials and clinical trial operations, including during COVID-19 conditions
  • Our network of 4 clinics and more than 3000 referring physicians across the province of Québec to ensure recruitment efficiency
  • Our direct patient population of thousands of patients who have been treated and followed over the past 6 years for a compelling screening
  • The engagement of its medical cannabis expert team of physicians and registered nurses to ensure appropriate patient monitoring
  • Our dedicated research team to provide robust data collection and ensure participant retention
  • Contemporary offices with a in-house biological sample laboratory, allowing for fluid patient visits

Each clinical trial has a specific set of variables that drive the costs. We would be more than happy to provide a cost estimate for your clinical trial.

Please contact us to book a consultation to learn how we can support your clinical research program.

JOIN US

Virtual Event: The importance of real-world data for cannabinoid research

Register today
1pm November 30th